{"id":"W2560907445","doi":"10.1200/jco.2011.29.15_suppl.tps226","title":"PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Bortezomib; Vincristine; Internal medicine; Rituximab; Oncology; International Prognostic Index; Lymphoma; Cyclophosphamide; Chemotherapy; Multiple myeloma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00133038,0.00144254,0.001351519,0.0004868472,0.0003069531,0.001042338,0.001064665,0.001083299,0.005821411],"category_scores_gemma":[0.001112387,0.0006672538,0.001459534,0.0004820844,0.0009898555,0.001155944,0.0006297181,0.00277678,0.0009489381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001145938,"about_ca_system_score_gemma":0.00148116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001257946,"about_ca_topic_score_gemma":0.003164348,"domain_scores_codex":[0.9996117,0.000190033,0.00001969677,0.0000621005,0.00004016517,0.00007641136],"domain_scores_gemma":[0.9994247,0.00009543007,0.0001428843,0.0000459091,0.00003354498,0.0002575865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.930055,0.0180688,0.002031037,0.0005469884,0.001103983,0.0001118162,0.0001196573,0.0007847406,0.008859412,0.0002777425,0.002475566,0.03556535],"study_design_scores_gemma":[0.8624495,0.1313656,0.00319614,0.00002389082,0.0004833883,0.00007092082,0.00004200525,0.0004934318,0.0006040387,0.0002723609,0.0009825969,0.00001621202],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906744,0.001770524,0.000582814,0.0008399048,0.0002237615,0.002767505,0.001210413,0.000137522,0.001793115],"genre_scores_gemma":[0.9832191,0.002339566,0.001877591,0.001699714,0.0001968472,0.005306831,0.001899527,0.00003570402,0.003425132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005821411,"threshold_uncertainty_score":0.01947457,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08384203089736851,"score_gpt":0.4152054060460393,"score_spread":0.3313633751486708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}